A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

BUFFALO, NEW YORK / ACCESS Newswire / June 23, 2025 / ZeptoMetrix® is pleased to announce the launch of NATtrol™ Influenza A ...

Scientists at the Broad Institute of MIT and Harvard have identified 4,208 previously unannotated open reading frames (ORFs) across 679 human-associated viral genomes using a high-throughput method ...

The role of insects in drug discovery is expanding, with biopharmaceuticals derived from insect cells offering sustainable ...

The global culture media market was valued at USD 4.65 billion in 2024 and is projected to reach USD 14.68 billion by 2034, registering a CAGR of 12.18% from 2025 to 2034. Increasing demand for ...

Cell culture-, recombinant protein- or nucleic acid-based vaccines an A/Wisconsin/67/2022 (H1N1)pdm09-like virus; an A/District of Columbia/27/2023 (H3N2)-like virus; and ...

In cells grown in culture, the virus was able to infect cells in both the usual way, and through MHC class II complexes. The structural compatibility between the virus and cell surface structures can ...

New approaches to influenza vaccine production are long overdue. In addition to more-rapid production, cell-culture–derived vaccines offer several advantages, including avoidance of microbial ...

Cell-culture or recombinant-based vaccines are recommended to contain an A/Wisconsin/67/2022 (H1N1)pdm09-like virus, an A/Massachusetts/18/2022 (H3N2)-like virus, and a B/Austria/1359417/2021 (B ...

We engineered barcodes into the A/California/04/2009 (pdmH1N1) strain of influenza virus with the G155E cell-culture adaptation mutation (Chen et al., 2010). Viruses with barcoded HA and NA segments ...

We still have an incomplete understanding of the proteins influenza A virus (IAV) uses to enter the host cell. The team led by GCIR member Prof. Mirco Schmolke, demonstrates in this article published ...